| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 3 | 2023 | 939 | 0.650 |
Why?
|
| Renin | 9 | 2017 | 647 | 0.470 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2023 | 3788 | 0.410 |
Why?
|
| Bed Rest | 7 | 2005 | 82 | 0.350 |
Why?
|
| Aldosterone | 8 | 2017 | 881 | 0.320 |
Why?
|
| Embolism | 2 | 2023 | 401 | 0.300 |
Why?
|
| Sodium, Dietary | 3 | 2017 | 426 | 0.280 |
Why?
|
| Piracetam | 3 | 2016 | 88 | 0.280 |
Why?
|
| Drug Hypersensitivity | 4 | 2017 | 903 | 0.260 |
Why?
|
| Pyridones | 2 | 2023 | 818 | 0.260 |
Why?
|
| Computer-Assisted Instruction | 3 | 2016 | 368 | 0.250 |
Why?
|
| Atrial Fibrillation | 5 | 2023 | 5182 | 0.240 |
Why?
|
| Weightlessness Simulation | 4 | 2006 | 41 | 0.240 |
Why?
|
| Thrombotic Microangiopathies | 2 | 2017 | 125 | 0.240 |
Why?
|
| Penicillins | 3 | 2017 | 404 | 0.240 |
Why?
|
| Anticonvulsants | 6 | 2016 | 1921 | 0.240 |
Why?
|
| Preoperative Care | 5 | 2018 | 2253 | 0.240 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2022 | 551 | 0.230 |
Why?
|
| Reminder Systems | 2 | 2021 | 389 | 0.210 |
Why?
|
| Renin-Angiotensin System | 5 | 2017 | 737 | 0.210 |
Why?
|
| Progesterone | 4 | 2010 | 752 | 0.210 |
Why?
|
| Seizures | 5 | 2016 | 2996 | 0.210 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2019 | 2270 | 0.210 |
Why?
|
| Anticoagulants | 7 | 2023 | 4855 | 0.210 |
Why?
|
| Diabetes Mellitus | 6 | 2018 | 5887 | 0.210 |
Why?
|
| Diet, Sodium-Restricted | 2 | 2017 | 291 | 0.200 |
Why?
|
| Middle Aged | 94 | 2022 | 223257 | 0.200 |
Why?
|
| Fertilization in Vitro | 5 | 2010 | 1301 | 0.200 |
Why?
|
| Adult | 96 | 2022 | 223307 | 0.190 |
Why?
|
| Hypotension, Orthostatic | 4 | 2006 | 258 | 0.190 |
Why?
|
| Hypoglycemia | 4 | 2019 | 896 | 0.190 |
Why?
|
| Stroke | 5 | 2023 | 9741 | 0.190 |
Why?
|
| Multiple Sclerosis | 5 | 2022 | 3229 | 0.190 |
Why?
|
| Cephalosporins | 3 | 2017 | 200 | 0.180 |
Why?
|
| Female | 117 | 2023 | 396520 | 0.180 |
Why?
|
| Sodium Chloride, Dietary | 3 | 2010 | 300 | 0.180 |
Why?
|
| Abortion, Induced | 2 | 2019 | 471 | 0.180 |
Why?
|
| Male | 104 | 2021 | 364142 | 0.180 |
Why?
|
| Counseling | 3 | 2019 | 1552 | 0.170 |
Why?
|
| Humans | 152 | 2023 | 766766 | 0.170 |
Why?
|
| Latent Tuberculosis | 1 | 2022 | 223 | 0.170 |
Why?
|
| Abortion, Eugenic | 1 | 2019 | 39 | 0.160 |
Why?
|
| Vacuum Curettage | 1 | 2019 | 44 | 0.160 |
Why?
|
| Tuberculosis | 2 | 2022 | 2011 | 0.160 |
Why?
|
| Gels | 2 | 2019 | 420 | 0.160 |
Why?
|
| Laxatives | 1 | 2019 | 95 | 0.160 |
Why?
|
| Inpatients | 5 | 2019 | 2565 | 0.150 |
Why?
|
| Substantia Nigra | 1 | 2020 | 346 | 0.150 |
Why?
|
| Angiotensin II | 6 | 2010 | 844 | 0.150 |
Why?
|
| Embryo Transfer | 3 | 2010 | 526 | 0.150 |
Why?
|
| Phenytoin | 2 | 2009 | 189 | 0.150 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2013 | 361 | 0.150 |
Why?
|
| Colonoscopy | 3 | 2021 | 1409 | 0.150 |
Why?
|
| Melatonin | 1 | 2003 | 670 | 0.150 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2018 | 105 | 0.150 |
Why?
|
| Respiratory Therapy | 1 | 2018 | 124 | 0.150 |
Why?
|
| Hospitals, General | 2 | 2021 | 804 | 0.150 |
Why?
|
| Hydrocortisone | 4 | 2004 | 1838 | 0.150 |
Why?
|
| Labor, Induced | 1 | 2019 | 153 | 0.150 |
Why?
|
| Neuroprotective Agents | 2 | 2016 | 956 | 0.140 |
Why?
|
| Lipocalins | 1 | 2018 | 160 | 0.140 |
Why?
|
| Aged | 61 | 2021 | 171343 | 0.140 |
Why?
|
| beta 2-Microglobulin | 1 | 2018 | 330 | 0.140 |
Why?
|
| Observation | 1 | 2019 | 310 | 0.140 |
Why?
|
| Cystatin C | 1 | 2018 | 272 | 0.140 |
Why?
|
| Coronary Sinus | 1 | 2017 | 85 | 0.130 |
Why?
|
| Sweetening Agents | 1 | 2019 | 291 | 0.130 |
Why?
|
| Bradykinin | 1 | 2016 | 205 | 0.130 |
Why?
|
| Leukemia | 6 | 1987 | 1521 | 0.130 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 2016 | 38 | 0.130 |
Why?
|
| Licensure | 1 | 2017 | 128 | 0.130 |
Why?
|
| Eye Pain | 1 | 2016 | 46 | 0.130 |
Why?
|
| Densitometry | 1 | 2016 | 150 | 0.130 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 1154 | 0.130 |
Why?
|
| Angioedemas, Hereditary | 1 | 2016 | 91 | 0.120 |
Why?
|
| Adaptation, Physiological | 4 | 2006 | 1313 | 0.120 |
Why?
|
| Nursing Staff, Hospital | 1 | 2019 | 350 | 0.120 |
Why?
|
| Cacao | 2 | 2013 | 98 | 0.120 |
Why?
|
| Plasma Exchange | 1 | 2016 | 160 | 0.120 |
Why?
|
| Carbon Monoxide | 1 | 2018 | 560 | 0.120 |
Why?
|
| Hyperglycemia | 2 | 2014 | 1389 | 0.120 |
Why?
|
| Drug Prescriptions | 2 | 2015 | 1663 | 0.120 |
Why?
|
| Caloric Restriction | 1 | 2017 | 303 | 0.120 |
Why?
|
| Nurse Practitioners | 2 | 2016 | 270 | 0.120 |
Why?
|
| Cardiovascular Deconditioning | 2 | 2005 | 9 | 0.120 |
Why?
|
| Eicosanoids | 1 | 2017 | 284 | 0.120 |
Why?
|
| Blood Pressure | 8 | 2017 | 8533 | 0.120 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2021 | 836 | 0.120 |
Why?
|
| Retrospective Studies | 33 | 2021 | 81635 | 0.120 |
Why?
|
| Puerperal Disorders | 1 | 2017 | 304 | 0.120 |
Why?
|
| Albuminuria | 1 | 2018 | 659 | 0.110 |
Why?
|
| Acetamides | 1 | 2016 | 260 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2017 | 308 | 0.110 |
Why?
|
| Thromboembolism | 1 | 2020 | 1003 | 0.110 |
Why?
|
| Weightlessness | 2 | 2005 | 103 | 0.110 |
Why?
|
| Epilepsy | 4 | 2012 | 3317 | 0.110 |
Why?
|
| Sepsis | 3 | 2018 | 2604 | 0.110 |
Why?
|
| Laryngeal Nerves | 1 | 2014 | 57 | 0.110 |
Why?
|
| Pain Measurement | 2 | 2016 | 3576 | 0.110 |
Why?
|
| Endocrine System | 2 | 2005 | 112 | 0.110 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 587 | 0.110 |
Why?
|
| Hypertension | 7 | 2005 | 8616 | 0.110 |
Why?
|
| Glucose | 2 | 2019 | 4340 | 0.110 |
Why?
|
| Patient Satisfaction | 4 | 2012 | 3485 | 0.110 |
Why?
|
| Vasoconstrictor Agents | 3 | 2017 | 654 | 0.110 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2021 | 941 | 0.110 |
Why?
|
| Adrenal Glands | 3 | 2001 | 556 | 0.110 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 810 | 0.110 |
Why?
|
| Head-Down Tilt | 7 | 2006 | 67 | 0.110 |
Why?
|
| Fatigue | 1 | 2020 | 1555 | 0.110 |
Why?
|
| Ketorolac | 1 | 2013 | 95 | 0.100 |
Why?
|
| Insulin | 3 | 2018 | 6608 | 0.100 |
Why?
|
| Blood Glucose | 5 | 2019 | 6422 | 0.100 |
Why?
|
| Brain Waves | 1 | 2017 | 416 | 0.100 |
Why?
|
| Luteal Phase | 2 | 2010 | 138 | 0.100 |
Why?
|
| Patient Care Planning | 1 | 2018 | 904 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 4 | 2017 | 7475 | 0.100 |
Why?
|
| Air Ambulances | 1 | 2014 | 93 | 0.100 |
Why?
|
| Ependymoma | 1 | 2016 | 326 | 0.100 |
Why?
|
| Osteoarthritis, Hip | 2 | 2010 | 409 | 0.100 |
Why?
|
| Blood Coagulation | 1 | 2019 | 1163 | 0.100 |
Why?
|
| Professional Competence | 1 | 2016 | 429 | 0.100 |
Why?
|
| Fibromyalgia | 3 | 2003 | 407 | 0.100 |
Why?
|
| Cystoscopy | 1 | 2012 | 128 | 0.100 |
Why?
|
| Bone Density | 6 | 2010 | 3491 | 0.100 |
Why?
|
| Laryngoscopy | 2 | 2015 | 714 | 0.100 |
Why?
|
| Allergy and Immunology | 1 | 2014 | 170 | 0.100 |
Why?
|
| Osteoporosis, Postmenopausal | 4 | 2003 | 399 | 0.100 |
Why?
|
| Surgical Procedures, Operative | 2 | 2014 | 1931 | 0.100 |
Why?
|
| Atovaquone | 1 | 2012 | 56 | 0.100 |
Why?
|
| Lipoxins | 2 | 2005 | 419 | 0.100 |
Why?
|
| Aspergillosis | 4 | 1987 | 242 | 0.100 |
Why?
|
| Aged, 80 and over | 23 | 2019 | 59550 | 0.100 |
Why?
|
| Ibuprofen | 1 | 2013 | 228 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 4 | 2019 | 7431 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 2593 | 0.100 |
Why?
|
| Hypothermia, Induced | 1 | 2017 | 754 | 0.100 |
Why?
|
| Docosahexaenoic Acids | 2 | 2017 | 915 | 0.100 |
Why?
|
| Lichen Planus, Oral | 1 | 2012 | 56 | 0.100 |
Why?
|
| Supratentorial Neoplasms | 2 | 2010 | 156 | 0.100 |
Why?
|
| Automobile Driving | 1 | 2017 | 442 | 0.100 |
Why?
|
| Shock, Septic | 1 | 2018 | 772 | 0.100 |
Why?
|
| Respiratory Insufficiency | 2 | 2018 | 1241 | 0.090 |
Why?
|
| Pneumocystis carinii | 1 | 2012 | 71 | 0.090 |
Why?
|
| Microglia | 1 | 2020 | 1370 | 0.090 |
Why?
|
| Platelet Factor 4 | 1 | 2011 | 131 | 0.090 |
Why?
|
| Length of Stay | 5 | 2018 | 6490 | 0.090 |
Why?
|
| Accidents, Traffic | 1 | 2017 | 818 | 0.090 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2011 | 104 | 0.090 |
Why?
|
| Education | 1 | 2014 | 531 | 0.090 |
Why?
|
| Carboplatin | 1 | 2014 | 789 | 0.090 |
Why?
|
| Lupus Nephritis | 2 | 2005 | 324 | 0.090 |
Why?
|
| Young Adult | 21 | 2019 | 59939 | 0.090 |
Why?
|
| Agranulocytosis | 4 | 1987 | 98 | 0.090 |
Why?
|
| Injections, Intramuscular | 5 | 2013 | 551 | 0.090 |
Why?
|
| Positron-Emission Tomography | 3 | 2020 | 6550 | 0.090 |
Why?
|
| Drug Utilization | 1 | 2017 | 1187 | 0.090 |
Why?
|
| Intensive Care Units | 3 | 2020 | 3799 | 0.090 |
Why?
|
| Spironolactone | 1 | 2014 | 415 | 0.090 |
Why?
|
| Plagiarism | 1 | 2010 | 22 | 0.090 |
Why?
|
| Statistics as Topic | 3 | 2007 | 2351 | 0.090 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2021 | 1911 | 0.090 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2012 | 241 | 0.090 |
Why?
|
| Vocal Cord Paralysis | 1 | 2014 | 275 | 0.090 |
Why?
|
| Airway Management | 1 | 2014 | 325 | 0.090 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 2704 | 0.090 |
Why?
|
| Vitamin D Deficiency | 3 | 2008 | 1349 | 0.090 |
Why?
|
| Warfarin | 1 | 2019 | 1494 | 0.090 |
Why?
|
| Treatment Outcome | 21 | 2022 | 65273 | 0.090 |
Why?
|
| Double-Blind Method | 9 | 2022 | 12430 | 0.090 |
Why?
|
| Brain | 7 | 2022 | 27159 | 0.090 |
Why?
|
| Intubation, Intratracheal | 2 | 2015 | 1359 | 0.090 |
Why?
|
| Patient Participation | 1 | 2019 | 1445 | 0.080 |
Why?
|
| Home Care Services | 1 | 2016 | 659 | 0.080 |
Why?
|
| Sound | 1 | 2012 | 257 | 0.080 |
Why?
|
| Atrophy | 3 | 2022 | 1631 | 0.080 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2010 | 116 | 0.080 |
Why?
|
| Premedication | 2 | 2009 | 245 | 0.080 |
Why?
|
| Microcirculation | 1 | 2014 | 1282 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 2232 | 0.080 |
Why?
|
| Boston | 7 | 2018 | 9346 | 0.080 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 806 | 0.080 |
Why?
|
| Skin Tests | 3 | 2017 | 630 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2019 | 2694 | 0.080 |
Why?
|
| Hospital Mortality | 3 | 2018 | 5343 | 0.080 |
Why?
|
| Health Behavior | 1 | 2021 | 2649 | 0.080 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 1998 | 663 | 0.080 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2010 | 187 | 0.080 |
Why?
|
| Flavonoids | 1 | 2012 | 447 | 0.080 |
Why?
|
| Analgesia | 1 | 2013 | 461 | 0.080 |
Why?
|
| Insulin Resistance | 3 | 2017 | 3989 | 0.080 |
Why?
|
| Desensitization, Immunologic | 1 | 2014 | 546 | 0.080 |
Why?
|
| Pre-Eclampsia | 2 | 2017 | 1256 | 0.080 |
Why?
|
| Uterine Hemorrhage | 1 | 2010 | 235 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1627 | 0.080 |
Why?
|
| Radioimmunoassay | 2 | 2000 | 861 | 0.080 |
Why?
|
| Coronary Circulation | 1 | 2014 | 1602 | 0.080 |
Why?
|
| Thromboxane B2 | 2 | 2005 | 143 | 0.080 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2016 | 1609 | 0.070 |
Why?
|
| Hospitals, Teaching | 2 | 2010 | 1156 | 0.070 |
Why?
|
| Acetanilides | 2 | 2020 | 168 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2016 | 1811 | 0.070 |
Why?
|
| Femur Neck | 1 | 2010 | 316 | 0.070 |
Why?
|
| Thyroidectomy | 1 | 2014 | 912 | 0.070 |
Why?
|
| Creatinine | 6 | 2018 | 1917 | 0.070 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 602 | 0.070 |
Why?
|
| Beverages | 1 | 2013 | 819 | 0.070 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 7871 | 0.070 |
Why?
|
| Adolescent | 24 | 2019 | 88904 | 0.070 |
Why?
|
| Videotape Recording | 1 | 2009 | 333 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 951 | 0.070 |
Why?
|
| Psychophysiologic Disorders | 1 | 2009 | 222 | 0.070 |
Why?
|
| Risk Factors | 15 | 2023 | 74881 | 0.070 |
Why?
|
| Absorptiometry, Photon | 3 | 2010 | 1707 | 0.070 |
Why?
|
| Hysterectomy | 1 | 2012 | 863 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 1 | 2014 | 947 | 0.070 |
Why?
|
| Acoustic Stimulation | 1 | 2012 | 1253 | 0.070 |
Why?
|
| Time Factors | 14 | 2019 | 40149 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2017 | 1516 | 0.070 |
Why?
|
| Consultants | 1 | 2007 | 57 | 0.070 |
Why?
|
| Subcutaneous Fat | 1 | 2010 | 401 | 0.070 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1988 | 304 | 0.070 |
Why?
|
| Antigens, Fungal | 1 | 1987 | 69 | 0.070 |
Why?
|
| Immobilization | 2 | 2006 | 227 | 0.070 |
Why?
|
| Paclitaxel | 1 | 2014 | 1727 | 0.070 |
Why?
|
| Blood Gas Analysis | 2 | 2018 | 382 | 0.070 |
Why?
|
| Potassium | 6 | 2010 | 1314 | 0.070 |
Why?
|
| Kidney | 6 | 2017 | 7074 | 0.070 |
Why?
|
| Allergens | 1 | 2014 | 1436 | 0.070 |
Why?
|
| Nitrogen | 1 | 1988 | 344 | 0.070 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2008 | 194 | 0.070 |
Why?
|
| Catheter Ablation | 2 | 2011 | 2786 | 0.060 |
Why?
|
| Accidental Falls | 2 | 2019 | 1078 | 0.060 |
Why?
|
| Follow-Up Studies | 14 | 2018 | 39309 | 0.060 |
Why?
|
| Prospective Studies | 13 | 2021 | 54871 | 0.060 |
Why?
|
| Leg | 3 | 2005 | 1087 | 0.060 |
Why?
|
| Sodium | 6 | 2010 | 1594 | 0.060 |
Why?
|
| Hip Fractures | 2 | 2008 | 996 | 0.060 |
Why?
|
| Pleural Neoplasms | 1 | 2010 | 584 | 0.060 |
Why?
|
| Aspergillus fumigatus | 1 | 1987 | 158 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2808 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2018 | 3618 | 0.060 |
Why?
|
| Aerospace Medicine | 1 | 2006 | 95 | 0.060 |
Why?
|
| Respiration | 1 | 2012 | 1654 | 0.060 |
Why?
|
| Maps as Topic | 1 | 1984 | 18 | 0.060 |
Why?
|
| Hemodynamics | 3 | 2005 | 4188 | 0.060 |
Why?
|
| Efficiency, Organizational | 1 | 2010 | 695 | 0.060 |
Why?
|
| Vaginal Creams, Foams, and Jellies | 3 | 2010 | 62 | 0.060 |
Why?
|
| Massachusetts | 4 | 2020 | 8891 | 0.060 |
Why?
|
| Intra-Abdominal Fat | 1 | 2010 | 624 | 0.060 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 944 | 0.060 |
Why?
|
| Mammography | 1 | 2016 | 2429 | 0.060 |
Why?
|
| Carcinoma | 1 | 2016 | 2324 | 0.060 |
Why?
|
| Needles | 1 | 2008 | 462 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3927 | 0.060 |
Why?
|
| Estradiol | 2 | 2010 | 1947 | 0.060 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2008 | 539 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 987 | 0.060 |
Why?
|
| Hypoglycemic Agents | 2 | 2018 | 3108 | 0.060 |
Why?
|
| Mesothelioma | 1 | 2010 | 774 | 0.060 |
Why?
|
| Medical Order Entry Systems | 1 | 2009 | 523 | 0.060 |
Why?
|
| Registries | 1 | 2020 | 8351 | 0.060 |
Why?
|
| Heparin | 1 | 2011 | 1636 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2017 | 14652 | 0.060 |
Why?
|
| Systole | 2 | 2003 | 935 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 36567 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2306 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2017 | 3001 | 0.060 |
Why?
|
| Reproducibility of Results | 6 | 2017 | 20144 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2003 | 1935 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2016 | 2520 | 0.060 |
Why?
|
| Angiotensinogen | 2 | 2001 | 161 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2019 | 24295 | 0.050 |
Why?
|
| Liver Neoplasms | 2 | 2011 | 4353 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 2011 | 1172 | 0.050 |
Why?
|
| Biometry | 1 | 2007 | 571 | 0.050 |
Why?
|
| Plethysmography | 3 | 2012 | 172 | 0.050 |
Why?
|
| Body Composition | 2 | 2011 | 2441 | 0.050 |
Why?
|
| Age Factors | 10 | 2010 | 18397 | 0.050 |
Why?
|
| Clomiphene | 1 | 2003 | 71 | 0.050 |
Why?
|
| Aspirin | 2 | 2005 | 3135 | 0.050 |
Why?
|
| Natriuresis | 1 | 2003 | 106 | 0.050 |
Why?
|
| Pilot Projects | 5 | 2022 | 8728 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 2672 | 0.050 |
Why?
|
| Sex Factors | 7 | 2010 | 10619 | 0.050 |
Why?
|
| Postoperative Complications | 3 | 2018 | 15831 | 0.050 |
Why?
|
| Glia Maturation Factor | 1 | 2022 | 13 | 0.050 |
Why?
|
| Etidronic Acid | 1 | 2003 | 63 | 0.050 |
Why?
|
| Meningioma | 1 | 2012 | 1221 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3110 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3232 | 0.050 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2003 | 133 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 3 | 2012 | 2505 | 0.050 |
Why?
|
| Renal Circulation | 1 | 2003 | 288 | 0.050 |
Why?
|
| Syncope | 1 | 2005 | 431 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2014 | 1514 | 0.050 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 5861 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 2016 | 9101 | 0.050 |
Why?
|
| Meningeal Neoplasms | 1 | 2012 | 1255 | 0.050 |
Why?
|
| Critical Care | 1 | 2015 | 2714 | 0.050 |
Why?
|
| Internship and Residency | 3 | 2012 | 5943 | 0.050 |
Why?
|
| Bilirubin | 2 | 2017 | 439 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2010 | 1716 | 0.050 |
Why?
|
| Predictive Value of Tests | 6 | 2018 | 15416 | 0.050 |
Why?
|
| Radiology | 1 | 2016 | 2105 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 2929 | 0.050 |
Why?
|
| Teaching | 1 | 2009 | 1171 | 0.050 |
Why?
|
| Pregnancy Rate | 3 | 2010 | 654 | 0.050 |
Why?
|
| Tuberculin Test | 1 | 2022 | 205 | 0.050 |
Why?
|
| France | 1 | 2003 | 495 | 0.050 |
Why?
|
| Thyrotropin | 1 | 2005 | 834 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 11513 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5795 | 0.050 |
Why?
|
| Appointments and Schedules | 2 | 2019 | 442 | 0.050 |
Why?
|
| Neutropenia | 1 | 1987 | 894 | 0.050 |
Why?
|
| Immunoradiometric Assay | 1 | 2001 | 20 | 0.050 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 2 | 2017 | 132 | 0.050 |
Why?
|
| Space Perception | 1 | 1984 | 468 | 0.050 |
Why?
|
| Weight Gain | 1 | 2011 | 2356 | 0.050 |
Why?
|
| Body Mass Index | 6 | 2017 | 13050 | 0.050 |
Why?
|
| Mothers | 1 | 2012 | 2208 | 0.050 |
Why?
|
| Fibrinolytic Agents | 2 | 2021 | 2078 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2003 | 731 | 0.050 |
Why?
|
| Italy | 1 | 2003 | 856 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 2001 | 166 | 0.040 |
Why?
|
| Diastole | 1 | 2003 | 784 | 0.040 |
Why?
|
| Protective Clothing | 1 | 2021 | 103 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 3411 | 0.040 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 3432 | 0.040 |
Why?
|
| Penicillin G | 1 | 2000 | 40 | 0.040 |
Why?
|
| Supine Position | 1 | 2001 | 208 | 0.040 |
Why?
|
| Cohort Studies | 8 | 2019 | 41710 | 0.040 |
Why?
|
| Emergency Medicine | 1 | 2009 | 1220 | 0.040 |
Why?
|
| Antiviral Agents | 3 | 1998 | 3070 | 0.040 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2009 | 1178 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 7119 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 4424 | 0.040 |
Why?
|
| Sex | 1 | 2000 | 52 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2011 | 11872 | 0.040 |
Why?
|
| Prognosis | 8 | 2018 | 29948 | 0.040 |
Why?
|
| Heroin Dependence | 1 | 1981 | 173 | 0.040 |
Why?
|
| Lung Diseases, Fungal | 3 | 1985 | 123 | 0.040 |
Why?
|
| Sunscreening Agents | 1 | 2021 | 138 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2012 | 3208 | 0.040 |
Why?
|
| Neurosyphilis | 1 | 2000 | 27 | 0.040 |
Why?
|
| Energy Intake | 1 | 1988 | 2142 | 0.040 |
Why?
|
| Pregnancy | 9 | 2019 | 30237 | 0.040 |
Why?
|
| Acyclovir | 2 | 1998 | 266 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2008 | 1217 | 0.040 |
Why?
|
| Kidney Transplantation | 2 | 2012 | 4278 | 0.040 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 15908 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 5368 | 0.040 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2000 | 240 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 2010 | 2645 | 0.040 |
Why?
|
| Disease Susceptibility | 2 | 2022 | 1791 | 0.040 |
Why?
|
| Ceftriaxone | 1 | 2000 | 176 | 0.040 |
Why?
|
| Carboxyhemoglobin | 1 | 2018 | 83 | 0.040 |
Why?
|
| Quality of Health Care | 2 | 2012 | 4306 | 0.040 |
Why?
|
| Collagen | 2 | 2005 | 2635 | 0.040 |
Why?
|
| Heart | 1 | 2012 | 4425 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2010 | 2190 | 0.040 |
Why?
|
| Public Opinion | 1 | 1982 | 484 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 888 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2009 | 5992 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2018 | 6869 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2022 | 1138 | 0.040 |
Why?
|
| General Surgery | 1 | 2009 | 1720 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2003 | 640 | 0.040 |
Why?
|
| Infusions, Intravenous | 3 | 2018 | 2228 | 0.040 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2017 | 54 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 1986 | 2730 | 0.040 |
Why?
|
| Infant Formula | 1 | 2019 | 192 | 0.040 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 21162 | 0.040 |
Why?
|
| Thrombosis | 1 | 2011 | 2953 | 0.040 |
Why?
|
| Cysts | 1 | 2003 | 685 | 0.040 |
Why?
|
| Premenopause | 3 | 2011 | 1039 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2004 | 848 | 0.040 |
Why?
|
| Foscarnet | 1 | 1997 | 36 | 0.040 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 85 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 2077 | 0.040 |
Why?
|
| Zona Glomerulosa | 1 | 2017 | 87 | 0.040 |
Why?
|
| Hyperparathyroidism | 1 | 1999 | 338 | 0.040 |
Why?
|
| Fetal Death | 1 | 2019 | 434 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2009 | 2418 | 0.040 |
Why?
|
| Electroencephalography | 2 | 2012 | 6282 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2019 | 382 | 0.030 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 1997 | 57 | 0.030 |
Why?
|
| Incidence | 4 | 2022 | 21525 | 0.030 |
Why?
|
| South Africa | 1 | 2022 | 1875 | 0.030 |
Why?
|
| Observer Variation | 1 | 2003 | 2614 | 0.030 |
Why?
|
| Organothiophosphorus Compounds | 2 | 1986 | 14 | 0.030 |
Why?
|
| Amifostine | 2 | 1986 | 39 | 0.030 |
Why?
|
| Parathyroidectomy | 1 | 1999 | 244 | 0.030 |
Why?
|
| Diuretics | 2 | 2014 | 614 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2017 | 222 | 0.030 |
Why?
|
| Hyperaldosteronism | 1 | 2000 | 252 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 434 | 0.030 |
Why?
|
| Putamen | 1 | 2017 | 288 | 0.030 |
Why?
|
| Venous Thromboembolism | 1 | 2009 | 1882 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1997 | 256 | 0.030 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1999 | 336 | 0.030 |
Why?
|
| Trifluridine | 1 | 1996 | 28 | 0.030 |
Why?
|
| Parathyroid Hormone | 2 | 2000 | 1791 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 2017 | 247 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2012 | 4858 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2019 | 737 | 0.030 |
Why?
|
| Ependyma | 1 | 2016 | 57 | 0.030 |
Why?
|
| Partial Thromboplastin Time | 1 | 2017 | 203 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 369 | 0.030 |
Why?
|
| Valine | 1 | 1998 | 410 | 0.030 |
Why?
|
| Case-Control Studies | 6 | 2017 | 22248 | 0.030 |
Why?
|
| Bicarbonates | 1 | 2017 | 293 | 0.030 |
Why?
|
| Thyroid Nodule | 1 | 2003 | 765 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2003 | 1417 | 0.030 |
Why?
|
| Aging | 4 | 2010 | 8731 | 0.030 |
Why?
|
| Self Administration | 1 | 2016 | 386 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2005 | 2258 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 865 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2006 | 2101 | 0.030 |
Why?
|
| Hormones | 1 | 1999 | 866 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 684 | 0.030 |
Why?
|
| Education, Medical | 1 | 2007 | 1744 | 0.030 |
Why?
|
| Automation | 1 | 2017 | 586 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 1972 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 1986 | 2662 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1999 | 702 | 0.030 |
Why?
|
| Glioma | 1 | 2010 | 3498 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2017 | 574 | 0.030 |
Why?
|
| Cyclophosphamide | 3 | 2011 | 2234 | 0.030 |
Why?
|
| Labor, Obstetric | 1 | 2017 | 313 | 0.030 |
Why?
|
| Hydrochlorothiazide | 1 | 2014 | 95 | 0.030 |
Why?
|
| Reference Values | 3 | 2010 | 4913 | 0.030 |
Why?
|
| Drug Tolerance | 2 | 2008 | 365 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2019 | 703 | 0.030 |
Why?
|
| Oncology Service, Hospital | 1 | 2014 | 55 | 0.030 |
Why?
|
| Allied Health Personnel | 1 | 2015 | 156 | 0.030 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1997 | 618 | 0.030 |
Why?
|
| Bone Marrow | 1 | 1984 | 2926 | 0.030 |
Why?
|
| Institutionalization | 1 | 1994 | 108 | 0.030 |
Why?
|
| Attitude to Health | 1 | 1982 | 2021 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 1889 | 0.030 |
Why?
|
| NAD | 1 | 2017 | 617 | 0.030 |
Why?
|
| Infusion Pumps | 1 | 2014 | 163 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 2017 | 587 | 0.030 |
Why?
|
| Norepinephrine | 2 | 2010 | 898 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 872 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 1001 | 0.030 |
Why?
|
| Infant, Newborn | 4 | 2019 | 26389 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 4853 | 0.030 |
Why?
|
| Anesthesia | 1 | 2004 | 1595 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2017 | 917 | 0.030 |
Why?
|
| Herpes Simplex | 1 | 1996 | 470 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 2 | 2005 | 596 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2015 | 354 | 0.030 |
Why?
|
| Epinephrine | 2 | 2010 | 782 | 0.030 |
Why?
|
| Enalapril | 1 | 2014 | 317 | 0.030 |
Why?
|
| Cognition | 2 | 2013 | 7057 | 0.030 |
Why?
|
| Standard of Care | 1 | 2017 | 569 | 0.030 |
Why?
|
| Cytokines | 2 | 2017 | 7438 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2014 | 826 | 0.020 |
Why?
|
| Professional Practice | 1 | 2014 | 314 | 0.020 |
Why?
|
| Neck | 1 | 2016 | 735 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 26310 | 0.020 |
Why?
|
| Adiponectin | 1 | 2017 | 1121 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 15657 | 0.020 |
Why?
|
| Homes for the Aged | 1 | 1994 | 273 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 222 | 0.020 |
Why?
|
| Pandemics | 2 | 2022 | 8735 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2261 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1998 | 838 | 0.020 |
Why?
|
| Postmenopause | 4 | 2003 | 2517 | 0.020 |
Why?
|
| Recovery of Function | 3 | 2008 | 2976 | 0.020 |
Why?
|
| Hyperemia | 1 | 2012 | 223 | 0.020 |
Why?
|
| Thalamus | 1 | 2017 | 1040 | 0.020 |
Why?
|
| Behavior | 1 | 1994 | 538 | 0.020 |
Why?
|
| Myoglobin | 1 | 2011 | 158 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2019 | 1363 | 0.020 |
Why?
|
| Pruritus | 1 | 2014 | 378 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2016 | 42577 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 830 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2021 | 2334 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 2014 | 385 | 0.020 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2010 | 58 | 0.020 |
Why?
|
| Communication Aids for Disabled | 1 | 2010 | 56 | 0.020 |
Why?
|
| Progesterone Congeners | 1 | 2010 | 42 | 0.020 |
Why?
|
| Biopsy | 3 | 2012 | 6779 | 0.020 |
Why?
|
| Apnea | 1 | 2012 | 193 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1997 | 1274 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 12245 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 1986 | 4527 | 0.020 |
Why?
|
| Corneal Diseases | 1 | 2016 | 535 | 0.020 |
Why?
|
| Back Pain | 1 | 2014 | 547 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2000 | 3227 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2010 | 305 | 0.020 |
Why?
|
| Ureter | 1 | 2012 | 364 | 0.020 |
Why?
|
| Hexokinase | 1 | 2010 | 125 | 0.020 |
Why?
|
| Bradycardia | 1 | 2012 | 304 | 0.020 |
Why?
|
| Video Recording | 1 | 2015 | 976 | 0.020 |
Why?
|
| Manometry | 1 | 2012 | 458 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2004 | 3230 | 0.020 |
Why?
|
| Antineoplastic Agents | 3 | 2011 | 13643 | 0.020 |
Why?
|
| Veins | 2 | 2004 | 769 | 0.020 |
Why?
|
| Foreign Medical Graduates | 1 | 2010 | 76 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2010 | 322 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2013 | 4018 | 0.020 |
Why?
|
| Infant | 3 | 2016 | 36461 | 0.020 |
Why?
|
| Hematocrit | 1 | 2011 | 622 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2013 | 1374 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2004 | 7868 | 0.020 |
Why?
|
| Survival Rate | 2 | 2016 | 12825 | 0.020 |
Why?
|
| Aorta | 1 | 2017 | 2043 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2011 | 527 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2011 | 416 | 0.020 |
Why?
|
| Resuscitation | 1 | 2014 | 681 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 4282 | 0.020 |
Why?
|
| Telemetry | 1 | 2010 | 201 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2017 | 1621 | 0.020 |
Why?
|
| Fluorouracil | 2 | 2011 | 1651 | 0.020 |
Why?
|
| United States | 4 | 2019 | 72951 | 0.020 |
Why?
|
| Patient Preference | 1 | 2016 | 946 | 0.020 |
Why?
|
| Social Environment | 1 | 1994 | 1012 | 0.020 |
Why?
|
| Mass Screening | 2 | 2021 | 5454 | 0.020 |
Why?
|
| Acute Disease | 5 | 1986 | 7241 | 0.020 |
Why?
|
| Heart Failure | 2 | 2003 | 11882 | 0.020 |
Why?
|
| Electromyography | 1 | 2014 | 1398 | 0.020 |
Why?
|
| Child | 5 | 2016 | 80668 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 1938 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2020 | 3464 | 0.020 |
Why?
|
| Platelet Count | 1 | 2011 | 784 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2011 | 608 | 0.020 |
Why?
|
| Propensity Score | 1 | 2016 | 1972 | 0.020 |
Why?
|
| Linear Models | 1 | 2018 | 5874 | 0.020 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 14762 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2012 | 498 | 0.020 |
Why?
|
| Obesity | 1 | 2010 | 13090 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 855 | 0.020 |
Why?
|
| Food Deprivation | 1 | 1988 | 115 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2010 | 392 | 0.020 |
Why?
|
| Probability | 2 | 2003 | 2476 | 0.020 |
Why?
|
| Disease Management | 1 | 2018 | 2533 | 0.020 |
Why?
|
| Methotrexate | 2 | 2011 | 1719 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 1987 | 205 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2011 | 967 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2011 | 1606 | 0.020 |
Why?
|
| Candidiasis | 1 | 1989 | 372 | 0.020 |
Why?
|
| Regression Analysis | 3 | 2010 | 6329 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 2 | 2010 | 2171 | 0.020 |
Why?
|
| Fruit | 1 | 2012 | 1166 | 0.020 |
Why?
|
| Vegetables | 1 | 2012 | 1199 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 2006 | 0.020 |
Why?
|
| Premature Birth | 1 | 2019 | 1830 | 0.020 |
Why?
|
| Software | 2 | 2012 | 4466 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 6307 | 0.020 |
Why?
|
| Body Water | 1 | 1988 | 337 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6512 | 0.020 |
Why?
|
| Deltaretrovirus | 1 | 1986 | 162 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 1587 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2012 | 1155 | 0.020 |
Why?
|
| Delirium | 1 | 2018 | 1698 | 0.020 |
Why?
|
| Midodrine | 1 | 2006 | 24 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1982 | 8045 | 0.020 |
Why?
|
| Psychometrics | 1 | 2016 | 3060 | 0.020 |
Why?
|
| Nursing Homes | 1 | 1994 | 1084 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2018 | 3043 | 0.020 |
Why?
|
| Models, Biological | 2 | 2017 | 9461 | 0.020 |
Why?
|
| Robotics | 1 | 2012 | 807 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 712 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 6850 | 0.020 |
Why?
|
| Hemophilia B | 1 | 1986 | 83 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 2083 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2005 | 10100 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2000 | 2971 | 0.020 |
Why?
|
| Comorbidity | 3 | 2012 | 10580 | 0.020 |
Why?
|
| Sclerosis | 1 | 2006 | 211 | 0.020 |
Why?
|
| Tilt-Table Test | 1 | 2005 | 80 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 1988 | 908 | 0.020 |
Why?
|
| Metoclopramide | 1 | 1985 | 51 | 0.020 |
Why?
|
| Leukopenia | 1 | 1986 | 213 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2017 | 4508 | 0.020 |
Why?
|
| Nurses | 1 | 2015 | 2503 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2007 | 271 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 2727 | 0.020 |
Why?
|
| Physician-Patient Relations | 2 | 2012 | 3266 | 0.020 |
Why?
|
| Histology | 1 | 2004 | 16 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 1885 | 0.020 |
Why?
|
| Neoplasms | 5 | 1986 | 22350 | 0.020 |
Why?
|
| Hand Strength | 1 | 2008 | 464 | 0.010 |
Why?
|
| Tumor Burden | 1 | 2011 | 1900 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2011 | 2229 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2010 | 1334 | 0.010 |
Why?
|
| Spatial Behavior | 1 | 1984 | 88 | 0.010 |
Why?
|
| Family | 2 | 2005 | 3209 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1988 | 675 | 0.010 |
Why?
|
| Medical Records | 1 | 2010 | 1408 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 684 | 0.010 |
Why?
|
| Endocrine Glands | 1 | 2004 | 101 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2017 | 3465 | 0.010 |
Why?
|
| Maternal Age | 1 | 2007 | 804 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2004 | 6962 | 0.010 |
Why?
|
| Hospitals | 1 | 2017 | 3888 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 10745 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2008 | 565 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2006 | 685 | 0.010 |
Why?
|
| Prevalence | 3 | 2010 | 15835 | 0.010 |
Why?
|
| Nurse-Patient Relations | 1 | 2004 | 101 | 0.010 |
Why?
|
| Benzothiadiazines | 1 | 2003 | 31 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 319 | 0.010 |
Why?
|
| Body Weight | 2 | 2000 | 4626 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2010 | 939 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2011 | 1129 | 0.010 |
Why?
|
| Self Report | 1 | 2015 | 3771 | 0.010 |
Why?
|
| Vasomotor System | 1 | 2004 | 208 | 0.010 |
Why?
|
| Antibodies | 1 | 2011 | 2421 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2012 | 2504 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2012 | 2141 | 0.010 |
Why?
|
| HIV Infections | 2 | 2000 | 17536 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2019 | 8066 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4570 | 0.010 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2003 | 77 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2014 | 2779 | 0.010 |
Why?
|
| Hospitalization | 2 | 2019 | 10823 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2011 | 3552 | 0.010 |
Why?
|
| Hemophilia A | 1 | 1986 | 359 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2010 | 2717 | 0.010 |
Why?
|
| Acetylation | 1 | 2005 | 1054 | 0.010 |
Why?
|
| Space Flight | 1 | 2005 | 219 | 0.010 |
Why?
|
| Amlodipine | 1 | 2003 | 84 | 0.010 |
Why?
|
| Health Personnel | 1 | 2016 | 3384 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2005 | 454 | 0.010 |
Why?
|
| Kinetics | 1 | 2010 | 6287 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 2003 | 262 | 0.010 |
Why?
|
| Laboratories, Hospital | 1 | 2004 | 192 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 2005 | 939 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2009 | 1259 | 0.010 |
Why?
|
| Control Groups | 1 | 1982 | 107 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2005 | 1478 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20708 | 0.010 |
Why?
|
| Medicine | 1 | 2010 | 944 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 244 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2003 | 350 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 2470 | 0.010 |
Why?
|
| Administration, Intravaginal | 1 | 2001 | 149 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 2028 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2009 | 1794 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 6222 | 0.010 |
Why?
|
| Potassium, Dietary | 1 | 2001 | 103 | 0.010 |
Why?
|
| Quality of Life | 2 | 2016 | 13476 | 0.010 |
Why?
|
| Placebos | 1 | 2005 | 1659 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 5753 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4142 | 0.010 |
Why?
|
| Arteries | 1 | 2006 | 1123 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2006 | 928 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2012 | 2039 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2002 | 614 | 0.010 |
Why?
|
| Odds Ratio | 2 | 2010 | 9661 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 8926 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2016 | 3850 | 0.010 |
Why?
|
| Cross Infection | 1 | 1989 | 1427 | 0.010 |
Why?
|
| Drug Evaluation | 3 | 1986 | 642 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2005 | 707 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2003 | 402 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3487 | 0.010 |
Why?
|
| Psychological Theory | 1 | 1981 | 172 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 1688 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 2003 | 539 | 0.010 |
Why?
|
| Citric Acid | 1 | 2000 | 124 | 0.010 |
Why?
|
| Ovulation Induction | 1 | 2001 | 276 | 0.010 |
Why?
|
| Logistic Models | 2 | 2005 | 13278 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 687 | 0.010 |
Why?
|
| Internal-External Control | 1 | 1981 | 348 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 2474 | 0.010 |
Why?
|
| Homeostasis | 1 | 2010 | 3342 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2009 | 2234 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8507 | 0.010 |
Why?
|
| Iron | 1 | 1988 | 1812 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 1985 | 1267 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2006 | 975 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2003 | 661 | 0.010 |
Why?
|
| Environment | 1 | 1984 | 1120 | 0.010 |
Why?
|
| Methadone | 1 | 1981 | 317 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2002 | 646 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11651 | 0.010 |
Why?
|
| Calcium | 2 | 2003 | 5783 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 1 | 1999 | 249 | 0.010 |
Why?
|
| Melanoma | 2 | 1988 | 5700 | 0.010 |
Why?
|
| Diphosphonates | 1 | 2003 | 625 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 1615 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4252 | 0.010 |
Why?
|
| Communication | 1 | 2012 | 3905 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 6558 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 11218 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 1241 | 0.010 |
Why?
|
| Vitamin D | 2 | 2003 | 3270 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 2188 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 4056 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1999 | 618 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1982 | 785 | 0.010 |
Why?
|
| Family Health | 1 | 2002 | 1254 | 0.010 |
Why?
|
| Prolactin | 1 | 1999 | 627 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 2004 | 839 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2008 | 2053 | 0.010 |
Why?
|
| Risk | 2 | 1986 | 9602 | 0.010 |
Why?
|
| Animals | 3 | 2017 | 168930 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2846 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2000 | 1638 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 1889 | 0.010 |
Why?
|
| Collagen Type I | 1 | 1999 | 616 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 12791 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1987 | 3561 | 0.010 |
Why?
|
| Data Collection | 1 | 2004 | 3321 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 18984 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2010 | 6596 | 0.010 |
Why?
|
| Demography | 1 | 1999 | 1641 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1999 | 2274 | 0.010 |
Why?
|
| Heart Rate | 1 | 2006 | 4207 | 0.010 |
Why?
|
| Intermediate Care Facilities | 1 | 1994 | 12 | 0.010 |
Why?
|
| Psychology, Social | 1 | 1994 | 52 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1996 | 702 | 0.010 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2003 | 1750 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2815 | 0.010 |
Why?
|
| Philadelphia | 1 | 1994 | 270 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1996 | 832 | 0.010 |
Why?
|
| Motivation | 1 | 1982 | 2020 | 0.010 |
Why?
|
| Restraint, Physical | 1 | 1994 | 184 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1999 | 1205 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 1999 | 1394 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2005 | 6408 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3139 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1994 | 642 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1998 | 2586 | 0.010 |
Why?
|
| Birth Weight | 1 | 2000 | 2123 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 4249 | 0.010 |
Why?
|
| Safety | 1 | 1996 | 1157 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6214 | 0.010 |
Why?
|
| Mental Health | 1 | 1986 | 3270 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2000 | 2030 | 0.010 |
Why?
|
| Skilled Nursing Facilities | 1 | 1994 | 406 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12064 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2003 | 2355 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1982 | 2817 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2003 | 5618 | 0.000 |
Why?
|
| Pregnancy Outcome | 1 | 2000 | 2971 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1986 | 10264 | 0.000 |
Why?
|
| Pennsylvania | 1 | 1989 | 615 | 0.000 |
Why?
|
| Models, Statistical | 1 | 2003 | 5091 | 0.000 |
Why?
|
| Hospitals, University | 1 | 1989 | 572 | 0.000 |
Why?
|
| Algorithms | 1 | 2008 | 14072 | 0.000 |
Why?
|
| Genotype | 1 | 2002 | 13036 | 0.000 |
Why?
|
| Catheters, Indwelling | 1 | 1989 | 436 | 0.000 |
Why?
|
| Peptides | 1 | 1999 | 4344 | 0.000 |
Why?
|
| False Negative Reactions | 1 | 1988 | 570 | 0.000 |
Why?
|
| Factor IX | 1 | 1986 | 76 | 0.000 |
Why?
|
| Actuarial Analysis | 1 | 1985 | 370 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1987 | 1622 | 0.000 |
Why?
|
| Pleurisy | 1 | 1985 | 54 | 0.000 |
Why?
|
| Akathisia, Drug-Induced | 1 | 1985 | 66 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1985 | 307 | 0.000 |
Why?
|
| Amphotericin B | 1 | 1985 | 140 | 0.000 |
Why?
|
| Inflammation | 1 | 2005 | 10860 | 0.000 |
Why?
|
| Paranasal Sinus Diseases | 1 | 1985 | 121 | 0.000 |
Why?
|
| Factor VIII | 1 | 1986 | 349 | 0.000 |
Why?
|
| Vomiting | 1 | 1986 | 652 | 0.000 |
Why?
|
| Mice | 1 | 2010 | 81889 | 0.000 |
Why?
|
| Communicable Disease Control | 1 | 1989 | 857 | 0.000 |
Why?
|
| Prednisone | 1 | 1988 | 1566 | 0.000 |
Why?
|
| Computers | 1 | 1985 | 589 | 0.000 |
Why?
|
| Patient Transfer | 1 | 1989 | 789 | 0.000 |
Why?
|
| Cough | 1 | 1985 | 599 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1996 | 9357 | 0.000 |
Why?
|
| Respiratory Sounds | 1 | 1985 | 702 | 0.000 |
Why?
|
| Hypotension | 1 | 1986 | 887 | 0.000 |
Why?
|
| Cause of Death | 1 | 1991 | 3716 | 0.000 |
Why?
|
| Disease Progression | 1 | 1997 | 13640 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1986 | 3804 | 0.000 |
Why?
|
| Epidemiologic Methods | 1 | 1984 | 1326 | 0.000 |
Why?
|
| Cisplatin | 1 | 1985 | 1655 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1987 | 1885 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 1988 | 9404 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1985 | 1276 | 0.000 |
Why?
|
| Fever | 1 | 1985 | 1607 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1988 | 8540 | 0.000 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1987 | 2763 | 0.000 |
Why?
|
| Radiography | 1 | 1985 | 6968 | 0.000 |
Why?
|
| Palliative Care | 1 | 1986 | 3640 | 0.000 |
Why?
|
| Pain | 1 | 1985 | 5098 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1985 | 12985 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1985 | 3636 | 0.000 |
Why?
|